Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

A rendering of Eli Lilly's planned plant expansion in Pleasant Prairie. The company is preparing for a next phase on a site ...

"Every day, I got on the scales and I still weighed exactly the same as before," Leith, 85, told U.K. paper 'The Times' ...

Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless” ...

NEW YORK CITY, NY / ACCESS Newswire / November 3, 2025 / In 2022, Zealthy Founder and CEO Kyle Robertson launchedZealthywith a clear mission: make high-quality healthcare more accessible and ...

The U.S. stock market sank from record heights as Wall Street sifted through mixed developments on everything from the ...

The company has $400 million, enough cash to potentially build off results from an early-stage leukemia yet this quarter.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...